Swati Sharma
MexicoHead of Media & Marketing
Expert insights, practical tools, personal stories of healing and growth — States of Mind supports every stage of your psychedelic journey
Psychedelic therapies are coming to mainstream medicine. Substances that have been dismissed for decades are now being studied by major institutions, discussed in therapist’s offices and living rooms around the world.
But most of the conversation still happens in clinical language and for more advanced audiences — excluding those who may need access to these therapies
States of Mind is here to change that.
We’re a psychedelic media platform with one mission: make the healing potential of psychedelics accessible to everyone who may need it.
Head of Media & Marketing
Senior Editor & Creative Producer
Content Editor
Product Builder
Social Media Content Editor
Product Designer
Our content is created and reviewed by a team of top writers and psychedelic experts; but it’s written to be accessible for anyone, from an advanced reader to someone new to the space.
First-person stories from real people who’ve experienced psychedelic therapy. Veterans. Teachers. Sceptics. Personal stories of healing.
Studies and emerging science, in plain English, always connected back to what it means for you.
Clear explainers on psychedelic substances, safety, integration, and the legal landscape. Whether you’re advanced, or just getting started, we’ll guide you through it.
Long-form conversations with researchers, therapists, and regular people trying to heal themselves and get better.
Practical resources and screenings to help you navigate the psychedelic space with confidence.
At States of Mind, we’re here to walk alongside you on your journey with psychedelic medicines. Our mission is to empower you with trustworthy, up-to-date information about psychedelic therapies — with a special focus on Europe, where we’ve seen a need for reliable resources and accessible support.
We founded States of Mind because we saw a gap: a lack of trusted, evidence-based resources for people seeking guidance and access to psychedelic therapies in Europe and beyond. Our goal is to bridge that gap by connecting you with credible information about psychedelic therapies that can open doors beyond traditional care models.
We welcome feedback and inquiries from our community of seekers, practitioners, and advocates.
PINK ELEPHANT, UNIPESSOAL LDA, a private limited liability company (“sociedade por quotas”) duly incorporated and existing under the laws of Portugal
Corporate number and tax identification number NIPC 519056582
Edifício Amoreiras Square, Rua Carlos Alberto da Mota Pinto, no. 17, second floor, 1070-313 Lisboa, Portugal
From thought-provoking podcasts and original stories to research breakthroughs and industry news, stay connected to the conversations that matter.
Joined by 12,000+ readers